 | Up a level |
2016
Mueller, Dirk, Fischer, Kirsten, Kaiser, Peter, Eichhorst, Barbara, Walshe, Ronald, Reiser, Marcel, Kellermann, Lenka, Borsi, Lisa, Civello, Daniele, Mensch, Alexander, Bahlo, Jasmin, Hallek, Michael, Stock, Stephanie and Fingerle-Rowson, Guenter (2016). Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Leuk. Lymphoma, 57 (5). S. 1130 - 1140. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
2015
Mensch, Alexander, Stock, Stephanie, Stollenwerk, Bjoern and Mueller, Dirk (2015). Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation. Pharmacoeconomics, 33 (3). S. 271 - 284. NORTHCOTE: ADIS INT LTD. ISSN 1179-2027
Mensch, Alexander, Stock, Stephanie, Stollenwerk, Bjoern and Mueller, Dirk (2015). Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation. Pharmacoeconomics, 33 (3). S. 271 - 284. NORTHCOTE: ADIS INT LTD. ISSN 1179-2027